A study just published in the Journal of Clinical Investigation describes what sounds like a very important advance in the treatment of genetically-caused diabetes.
The study is iPSC-derived β cells model diabetes due to glucokinase deficiency. Haiqing Hua
et. al Journal of Clinical Investigation, 2013; DOI: 10.1172/JCI67638
To better understand what was done here, read Science Daily: